Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review
Introduction: Immune-related neurologic toxicities are uncommon but serious adverse events that may be associated with the use of immune checkpoint inhibitors. The objective of this review is to assess the incidence and risk of neurologic toxicities which are potentially immune-related and occur wit...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
31 May 2017
|
| In: |
Expert review of neurotherapeutics
Year: 2017, Jahrgang: 17, Heft: 7, Pages: 725-736 |
| ISSN: | 1744-8360 |
| DOI: | 10.1080/14737175.2017.1336088 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1080/14737175.2017.1336088 Verlag, Volltext: https://doi.org/10.1080/14737175.2017.1336088 
|
| Verfasserangaben: | Mostafa Eltobgy, Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Arianeb Mehrabi, Othmar Schöb, Anwar Giryes, Michael Decker, Omar Abdel-Rahman |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1584508078 | ||
| 003 | DE-627 | ||
| 005 | 20220815065628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181127s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14737175.2017.1336088 |2 doi | |
| 035 | |a (DE-627)1584508078 | ||
| 035 | |a (DE-576)514508078 | ||
| 035 | |a (DE-599)BSZ514508078 | ||
| 035 | |a (OCoLC)1341024117 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Eltobgy, Mostafa |e VerfasserIn |0 (DE-588)1172313636 |0 (DE-627)104111768X |0 (DE-576)514507551 |4 aut | |
| 245 | 1 | 0 | |a Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors |b a systematic review |c Mostafa Eltobgy, Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Arianeb Mehrabi, Othmar Schöb, Anwar Giryes, Michael Decker, Omar Abdel-Rahman |
| 264 | 1 | |c 31 May 2017 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.11.2018 | ||
| 520 | |a Introduction: Immune-related neurologic toxicities are uncommon but serious adverse events that may be associated with the use of immune checkpoint inhibitors. The objective of this review is to assess the incidence and risk of neurologic toxicities which are potentially immune-related and occur with immune checkpoint treatment of solid tumors.Areas covered: PubMed database has been searched till January 2017. Clinical trials, case series and case reports reporting the occurrence of immune-related neurologic toxicities in solid tumor patients treated with immune checkpoint inhibitors were included. Eighteen trials with 4469 participants were included. The most common neurologic toxicities reported with these agents included sensory and motor peripheral neuropathies. Moreover, 17 case reports describing immune-related neurological events occurring with 22 patients were included.Expert commentary: Immune-related neurological toxicities occur uncommonly in cancer patients treated immune checkpoint inhibitors. Further studies are needed to better describe the course of these events (i.e. time to onset, time to resolution and responsiveness to different immunosuppressives). | ||
| 650 | 4 | |a atezolizumab | |
| 650 | 4 | |a neurologic events | |
| 650 | 4 | |a nivolumab | |
| 650 | 4 | |a Pembrolizumab | |
| 700 | 1 | |a Oweira, Hani |e VerfasserIn |0 (DE-588)1155884973 |0 (DE-627)1018363904 |0 (DE-576)501927395 |4 aut | |
| 700 | 1 | |a Mehrabi, Arianeb |d 1967- |e VerfasserIn |0 (DE-588)137664583 |0 (DE-627)594829763 |0 (DE-576)304831263 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of neurotherapeutics |d Abingdon : Taylor & Francis Group, 2001 |g 17(2017), 7, Seite 725-736 |h Online-Ressource |w (DE-627)355690497 |w (DE-600)2090856-8 |w (DE-576)398100063 |x 1744-8360 |7 nnas |a Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors a systematic review |
| 773 | 1 | 8 | |g volume:17 |g year:2017 |g number:7 |g pages:725-736 |g extent:12 |a Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors a systematic review |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14737175.2017.1336088 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1080/14737175.2017.1336088 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181127 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 137664583 |a Mehrabi, Arianeb |m 137664583:Mehrabi, Arianeb |d 910000 |d 910200 |e 910000PM137664583 |e 910200PM137664583 |k 0/910000/ |k 1/910000/910200/ |p 6 | ||
| 998 | |g 1155884973 |a Oweira, Hani |m 1155884973:Oweira, Hani |p 2 | ||
| 999 | |a KXP-PPN1584508078 |e 3034176570 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"note":["Gesehen am 03.09.15"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2001 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"title":[{"title":"Expert review of neurotherapeutics","title_sort":"Expert review of neurotherapeutics"}],"recId":"355690497","disp":"Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors a systematic reviewExpert review of neurotherapeutics","origin":[{"publisherPlace":"Abingdon ; London ; London ; London","publisher":"Taylor & Francis Group ; Future Drugs ; Expert Reviews ; Informa Healthcare","dateIssuedKey":"2001","dateIssuedDisp":"2001-"}],"id":{"issn":["1744-8360"],"zdb":["2090856-8"],"eki":["355690497"]},"part":{"volume":"17","pages":"725-736","text":"17(2017), 7, Seite 725-736","extent":"12","year":"2017","issue":"7"}}],"note":["Gesehen am 27.11.2018"],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"31 May 2017"}],"id":{"doi":["10.1080/14737175.2017.1336088"],"eki":["1584508078"]},"recId":"1584508078","name":{"displayForm":["Mostafa Eltobgy, Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Arianeb Mehrabi, Othmar Schöb, Anwar Giryes, Michael Decker, Omar Abdel-Rahman"]},"title":[{"title":"Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors","subtitle":"a systematic review","title_sort":"Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors"}],"person":[{"display":"Eltobgy, Mostafa","family":"Eltobgy","role":"aut","given":"Mostafa"},{"role":"aut","given":"Hani","family":"Oweira","display":"Oweira, Hani"},{"display":"Mehrabi, Arianeb","family":"Mehrabi","role":"aut","given":"Arianeb"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"12 S."}]} | ||
| SRT | |a ELTOBGYMOSIMMUNERELA3120 | ||